Remogliflozin
-
Mankind Pharma signs up with Glenmark Pharmaceuticals for co-marketing of Remogliflozin Etabonate
New Delhi: Mankind Pharmaceuticals Ltd. and Glenmark Pharmaceuticals Ltd. today inked a sub-licensing agreement to co-market sodium glucose co-transporter-2 (SGLT2) inhibitor,…
Read More »